Replies to post #315148 on Avid Bioservices Inc (CDMO)

[Threes]

In it's usual lack of transparency we do not know much about the relationship between PPHM and MSK/NCCN.
We give them 2 million they do small test to probe the IP. Then what, PPHM mentioned partnering, but, seems like no takers that we know of.

What next, do we give MSK 10 to 15 million to initiate Phase1 trials, where do they go with the IP and no takers.

Who is paying the bills.
What would MSK say if they were informed there is no money. Would they walk away from PS. Would they find a way to include it in Pd-1 trials with the right Biomarkers.

Why don't shareholders know the answers.

[biopharm]

Maybe it would be more realistic to see every company that Ludwig / MSK is invested in and the reps on their boards just as Dr Wolchok also sits on many scientific advisory boards and imagine PS Targeting being spread throughout the land of all their investments...

Would now that $2 Million for 1% stake seem unreasonable....? Likely not....actually a steal for MSK

[north40000]

Contrary to James’ hypothesis that you quote, does MSKCC/Ludwig have to invest any $$$ at all to have one or more of its personnel(think Rosen/Wolchok) invited to be on PPHM or AVID BOD as a non- employee member?

Could the present PPHM/AVID relationship of parent and sub be restructured or redesignated by current BOD as AVID the parent and PPHM the sub(in light of unknown or insufficient present value of PPHM’s R&D platform, not worth pursuing immediately with further $$$ invested), with or without SH approval? That idea seems a slam dunk of being approved in either circumstance, eh? The Avid BOD and management would then have the task of partnering, licensing and/or selling the sub’s R&D platform, all in accord with Ronin’s thoughts of best way of achieving value and the tenets of SK’s statement that PPHM is in a transition state to become a CDMO.

All of the above paragraph would seem to require UTSW’s approval or agreement as owner of most of the IP patented technology to which the entity PPHM has an exclusive license.
Some patents are co-owned by UTSW and PPHM. What happens next should that IP be partnered, licensed or sold? Presumably, something must come back to UTSW if successfully commercially developed Later....